Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Back to institutions

Boehringer Ingelheim (Sweden)

Stockholmcompany

106

Works

5,288

Citations

38

h-index

Top Research Topics

Diabetes Treatment and Management Cardiovascular Function and Risk Factors Pancreatic function and diabetes

Top Researchers

Jeffrey L. Saver

1,613 works104,129 citationsh-index: 153

Recent Research

63323 Signs, symptoms, and impacts of Netherton syndrome on health-related quality of life and overall functioning as reported by patients and caregivers

Amy S. Paller,Stephan Weidinger,et al.

20250 citations

Boehringer Ingelheim (Sweden) | Researchclopedia

Diabetes Management and Research

Metabolism, Diabetes, and Cancer

Heart Failure Treatment and Management

Asthma and respiratory diseases

Acute Ischemic Stroke Management

Respiratory and Cough-Related Research

Venous Thromboembolism Diagnosis and Management

Atrial Fibrillation Management and Outcomes

Chronic Obstructive Pulmonary Disease (COPD) Research

Ralph L. Sacco University of Miami

942 works90,876 citationsh-index: 120

Andrew M. Demchuk MACOM (United States)

887 works67,728 citationsh-index: 113

Martin R. Farlow Harvard University

807 works61,420 citationsh-index: 116

Hans‐Christoph Diener Institut für Medizinische Informatik, Biometrie und Epidemiologie

713 works45,166 citationsh-index: 95

Steven Warach Ascension

408 works35,427 citationsh-index: 87

Treatment Pattern of Heart Failure Patients in Sweden During 2021–2023 in Relation to Updated Treatment Recommendations

Michaela Eklund,Magnus Husberg,et al.

20252 citations

Baseline characteristics of patients enrolled in the FIBRONEER-ILD trial of nerandomilast (BI 1015550)

Francesco Bonella,Toby M. Maher,et al.

20250 citations

Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trial

David Fitchett,Bernard Zinman,et al.

202411 citations

Empagliflozin Use Is Associated With Lower Risk of All‐Cause Mortality, Hospitalization for Heart Failure, and End‐Stage Renal Disease Compared to DPP‐4i in Nordic Type 2 Diabetes Patients: Results From the EMPRISE (Empagliflozin Comparative Effectiveness and Safety) Study

Gisle Langslet,Thomas Nyström,et al.

20241 citations

Prolonged Sick Leave Before and After Diagnosis of Generalized Pustular Psoriasis: A Swedish Population-based Register Study

Sofia Löfvendahl,Jenny M. Norlin,et al.

20236 citations